Floridians Against Socialized Healthcare

Government-run health care has proven to be heartless and uncaring — and the inferior treatments it provides come with a very steep price tag

[Floridians Against Socialized Healthcare @FlashFlorida]

🇺🇸 Patient safety comes first.
The FDA placed a Chinese pharmaceutical manufacturer on import alert after uncovering serious quality-control concerns involving GLP-1 drug ingredients shipped to the United States. Every American should know about this story.
https://t.co/Fd2mkCp8Ye

[Floridians Against Socialized Healthcare @FlashFlorida]

Washington politicians see a headline. Patients live with the consequences.
"Most Favored Nation" drug pricing may sound appealing, but it risks importing foreign socialist price controls, weakening medical innovation, and reducing access to future treatments.
America should lead the world in cures—not copy the policies that discourage them.
@SenRickScott @SenAshleyMoody @RepLaurelLee @RepGregSteube @RepAaronBean @DrNealDunnFL2 @RepKatCammack @RepGusBilirakis @RepDonaldsPress

https://t.co/lWUjf9axrj

[Floridians Against Socialized Healthcare @FlashFlorida]

Cheap GLP-1s from unverified online sellers may sound tempting — but experts warn the risks are real: contamination, incorrect dosing, counterfeit products, and zero oversight.
This article breaks down how federal delays helped fuel a booming gray market that’s now incredibly hard to contain. @SenRickScott @SenAshleyMoody @RepGusBilirakis @RepLaurelLee @DrNealDunnFL2 @RepCarlos https://t.co/ZEVHy6B137

[Floridians Against Socialized Healthcare @FlashFlorida]

Europe’s healthcare systems often delay or deny access to breakthrough medicines using rigid cost-effectiveness thresholds. For individuals with Down syndrome and other disabilities, those formulas can become deeply discriminatory in practice. America must protect patient access, innovation, and equal dignity in healthcare. @DSAofCentralFL @DSFFlorida @SenRickScott @SenAshleyMoody @RepLaurelLee @RepGusBilirakis @RepCarlos @DrNealDunnFL2 @RepKatCammack
https://t.co/CKBs9UwDvR

[Floridians Against Socialized Healthcare @FlashFlorida]

Patients searching for affordable semaglutide and tirzepatide options are increasingly turning to compounded products sold online, through telehealth platforms, and via aggressive social advertising. But behind some of these products are foreign ingredient suppliers operating outside meaningful FDA oversight. @SenRickScott @SenAshleyMoody @RepGusBilirakis @DrNealDunnFL2 @RepLaurelLee @RepKatCammack https://t.co/PxS2Odbd3C

[Floridians Against Socialized Healthcare @FlashFlorida]

The explosion of compounded GLP-1 medications has created a dangerous gray market that too many Americans still don’t fully understand. @RepGusBilirakis @RepLaurelLee @RepAaronBean @RepCarlos @DrNealDunnFL2 @Kat_Cammack https://t.co/WI3NT0huw1

[Floridians Against Socialized Healthcare @FlashFlorida]

Supporters of MFN promise massive savings, but key details remain unclear—and even experts say the savings estimates rely on highly speculative modeling. America should pursue real healthcare reform, not price-control experiments. @senrickscott @senashleymoody @repgusbilirakis @RepCarlos @DrNealDunnFL2 https://t.co/U1NTejIT8S

[Floridians Against Socialized Healthcare @FlashFlorida]

History has shown time and again: price controls don’t work. “Most Favored Nation” drug pricing is just another version—tying U.S. prices to foreign government mandates and risking fewer new treatments for patients. That’s not reform, it’s repeating past mistakes. @RepKatCammack @SenRickScott @SenAshleyMoody @RepGusBilirakis @DrNealDunnFL2 Instead of importing foreign price controls through MFN, we should focus on solutions that strengthen innovation and ensure other countries pay their fair share. Undermining America’s leadership in drug development helps no one in the long run. https://t.co/mtrA9Aa92K

[Floridians Against Socialized Healthcare @FlashFlorida]

MFN pricing may promise lower costs, but it comes with serious tradeoffs: less certainty for investment, disrupted markets, and potential slowdowns in innovation. Price controls always have consequences—and patients often feel them first.@SenAshleyMoody @SenRickScott @DrNealDunnFL2 @RepGregSteube @RepGusBilirakis @RepKatCammack @RepLaurelLee https://t.co/XhqjHub5m2

[Floridians Against Socialized Healthcare @FlashFlorida]

America leads in medical innovation because we rely more on market incentives—not government price-setting. Importing foreign pricing through MFN risks moving us closer to the same systems that limit access and delay new treatments abroad. @SenRickScott @SenAshleyMoody @RepKatCammack @DrNealDunnFL2 @RepGusBilirakis @RepLaurelLee https://t.co/LNmkf9cUFv

[Floridians Against Socialized Healthcare @FlashFlorida]

America leads the world in medical innovation because we rely on market incentives—not government price caps. MFN pricing borrows from socialized systems abroad, risking fewer breakthroughs and less access here at home. @RepGusBilirakis @DrNealDunnFL2 @SenAshleyMoody https://t.co/LNmkf9cUFv

[Floridians Against Socialized Healthcare @FlashFlorida]

“Most Favored Nation” drug pricing sounds fair—but it imports foreign price controls into our healthcare system. That means fewer incentives to innovate, fewer breakthrough treatments, and ultimately fewer choices for patients. Free markets drive cures, not government price setting. @Kat_Cammack @RepGusBilirakis @RepLaurelLee @DrNealDunnFL2
https://t.co/z709xfhDhp

[Floridians Against Socialized Healthcare @FlashFlorida]

History lesson required. While the intent behind Trumps most favored nation drug pricing proposal may be to lower prescription cost for consumers, the historical context and potential economic repercussions extract lessons from Nixon's price controls. Without a comprehensive strategy that considers market dynamics and the need for innovation, the MFN policy risk mirrors past mistakes, leading to negative outcomes for both consumers and the healthcare market as a whole. Similar to Nixon's quick-fix approach to inflation, the MFN proposal might only serve as a Band-Aid, causing more damage than fix. Codifying MFN into law is guaranteed to distort markets, create shortages and result in fewer life-saving medication development. @SenRickScott @DrNealDunnFL2 @RepKatCammack @RepGusBilirakis @VernBuchanan @RepGregSteube

[James Blair @JamesBlairUSA]

Totally wrong take.

Nobody proposed “socialist price controls”.

President Trump is breaking foreign price controls which force Americans to pay more so people in other countries can pay less for the same drug.

Now, foreigners pay their fair share, & American prices go down.

[Floridians Against Socialized Healthcare @FlashFlorida]

Florida’s legal reforms reduced abusive lawsuits and stabilized markets. Now, the House must act to strengthen them — support HB 1157 and give Sunshine to litigation financing so courts focus on merit, not hedge-fund profits. @TraciLKoster @Daniel_PerezFL https://t.co/EcAvmeK1xm

[Floridians Against Socialized Healthcare @FlashFlorida]

They are an even bigger threat to Florida @SenRickScott @SenAshleyMoody

[Tom Cotton @SenTomCotton]

Counterfeit drugs from China pose a real threat to Arkansans. The Combatting Counterfeit Pharmaceuticals Act will establish a program to identify and sanction the foreign traffickers and manufacturers trying to do us harm. https://t.co/42mdtHqcnh

[Floridians Against Socialized Healthcare @FlashFlorida]

Americans deserve safe, legitimate medications — not unsafe knockoffs flooding the market. But instead of empowering markets to produce affordable, high-quality drugs here at home, regulators push more red tape. Let’s support domestic innovation & patient choice, not bureaucratic barriers. @SenRickScott @RepKatCammack @RepCarlos @RepGregSteube @DrNealDunnFL2 @RepAaronBean @JimmyPatronis @VernBuchanan https://t.co/qa294X7xsU

[Floridians Against Socialized Healthcare @FlashFlorida]

Public policy should focus on breaking down barriers to competition — like expanding access to over-the-counter medications — not imposing foreign price controls that undermine America’s world-leading biopharmaceutical sector. @SenRickScott @RepCarlos @VernBuchanan @gregsteube @Kat_Cammack @DrNealDunnFL2 https://t.co/nvqZfDQ3y2

[Steve Scalise @SteveScalise]

It’s clear: the American people want SECURE elections.

They want VOTER ID.

@ChipRoyTX’s SAVE America Act requires voters to present a photo ID to be able to vote and proof of citizenship to register to vote in federal elections.

Let’s get it DONE.

[Benny Johnson @bennyjohnson]

🚨CNN’s Pollster issues DEATH SENTENCE for Democrats on Voter ID:

Black Voters: 76% want it
White voters: 85% want it
Latino voters: 82% want it

The Senate must pass the SAVE Act.

[Floridians Against Socialized Healthcare @FlashFlorida]

Transparency is not the same as control. We support clarity in drug pricing for consumers — but reject government-mandated price ceilings that mimic foreign systems that stifle access and innovation. @SenRickScott @DrNealDunnFL2 @RepGregSteube @RepGusBilirakis @VernBuchanan @RepKatCammack @RepAaronBean @MikeHaridopolos @JimmyPatronis https://t.co/nvqZfDQ3y2